Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

Abstract

Emerging evidence indicates that the Achilles' heel of cancer immunotherapies is often the complex interplay of tumor-derived factors and deviant host properties, which involve a wide range of immune elements in the lymphoid and myeloid compartments. Regulatory lymphocytes, tumor-conditioned myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages, and dysfunctional and immature dendritic cells take part in a complex immunoregulatory network. Despite the fact that some mechanisms governing tumor-induced immune tolerance and suppression are starting to be better understood and their complexity dissected, little is known about the diachronic picture of immune tolerance. Based on observations of MDSCs, we present a time-structured and topologically consistent idea of tumor-dependent tolerance progression in tumor-bearing hosts.

IFN-γ Receptor Signaling Regulates Memory CD8+ T Cell Differentiation

“…This suggests that IFN-gR signaling initiates different mechanisms in CD11b + cells, which independently control cell-cycle progression and CD62L downregulation of recently primed CD8 + T cells. CD11b + cells counterregulate T cell responses in several experimental systems (31,32). For example, IFN-g leads to NO production by CD11b + cells, which, in turn, suppresses T cell expansion (33,34).…”

Naringenin reduces lung metastasis in a breast cancer resection model

“…The regulation of the immune system is a complicated process and involves many types of cells, such as MDSCs and tumor-associated macrophages (TAMs) (Marigo et al, 2008;Coffelt et al, 2009;Gabrilovich and Nagaraj, 2009). Whether the inhibition of Tregs by naringenin plays a definitive role in T cell restoration should be clarified in future studies.…”

Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Fas lpr mouse

“…These cells have been reported to express CD11b and GR-1 in mouse models (1)(2)(3)(4). In tumor microenvironment, MDSCs inhibit T cell activation via arginase (ARG)-1 and nitric oxidase activation, resulting in tumor growth (4).…”